April 2024
1. PHILLIPS K, Nirantharakumar K, Wakerley BR, Crowe FL, et al
   Trends in the prevalence and pharmacological management of migraine during pregnancy in the UK, 2000-2018.
   J Neurol Neurosurg Psychiatry. 2024 Apr 3:jnnp-2024-333530.
   

   >> Share

   
   January 2022
2. DE VRIES LENTSCH S, Al-Hassany L, Ferrari MD, Terwindt GM, et al
   CGRP-mediated trigeminovascular reactivity in migraine patients treated with erenumab.
   J Neurol Neurosurg Psychiatry. 2022 Jan 27. pii: jnnp-2021-327992.
   

   >> Share

   
   November 2021
3. FERRARI MD, Reuter U, Goadsby PJ, Paiva da Silva Lima G, et al
   Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: results from the LIBERTY study.
   J Neurol Neurosurg Psychiatry. 2021 Nov 29. pii: jnnp-2021-327480.
   

   >> Share

   
   September 2021
4. PULEDDA F, Schankin CJ, O'Daly O, Ffytche D, et al
   Localised increase in regional cerebral perfusion in patients with visual snow syndrome: a pseudo-continuous arterial spin labelling study.
   J Neurol Neurosurg Psychiatry. 2021;92:918-926.
   

   >> Share

   
   January 2021
5. RAY JC, Kapoor M, Stark RJ, Wang SJ, et al
   Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects.
   J Neurol Neurosurg Psychiatry. 2021 Jan 25. pii: jnnp-2020-324674.
   

   >> Share

   
   
6. LANTERI-MINET M, Goadsby PJ, Reuter U, Wen S, et al
   Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2-4 preventives were not useful: results from the LIBERTY study.
   J Neurol Neurosurg Psychiatry. 2021 Jan 5. pii: jnnp-2020-324396.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share